BELITE BIO, INC — insider transactions
4 transactions on record · BLTE · CIK 1889109
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
4
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$132K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$40.3K
2026-08-12
Director share, 12m
100.0%
of transactions where role is stated
Current run
4 sells
consecutive same-direction transactions
Net 3m flow
-$132K
purchases minus sales
Total on record
4
Transactions
4 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 2026-08-12 | 2 | Lin Yu-Hsin | Director, Chief Executive Officer | Open market sale | 142 | $180.00 | $25.6K | filing |
| 2026-08-14 | 2026-08-12 | 2 | Chuang Hao-Yuan | Director, Chief Financial Officer | Open market sale | 144 | $180.00 | $25.9K | filing |
| 2026-08-14 | 2026-08-12 | 2 | Lin Yu-Hsin | Director, Chief Executive Officer | Open market sale | 223 | $180.57 | $40.3K | filing |
| 2026-08-14 | 2026-08-12 | 2 | Chuang Hao-Yuan | Director, Chief Financial Officer | Open market sale | 223 | $180.57 | $40.3K | filing |